Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Longerich

Showing results (91-100 of 227) with videos related to

Pageof 23
Sort By:
International Journal of Oncology|November 19, 2014
Protumorigenic role of Timeless in hepatocellular carcinomaNahla Elgohary, Rossella Pellegrino, Olaf Neumann, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|January 19, 2010
Lipid droplet-associated PAT-proteins show frequent and differential expression in neoplastic steatogenesisBeate K Straub, Esther Herpel, Stephan Singer, et al.
Gastroenterology Research and Practice|August 9, 2020
Mouse Models of Nonalcoholic Steatohepatitis: Head-to-Head Comparison of Dietary Models and Impact on Inflammation and Animal WelfareAndreas Kroh, Vanina Ivanova, Hannah Drescher, et al.
Hepatology (Baltimore, Md.)|June 4, 2013
Posttranscriptional destabilization of the liver-specific long noncoding RNA HULC by the IGF2 mRNA-binding protein 1 (IGF2BP1)Monika Hämmerle, Tony Gutschner, Hannah Uckelmann, et al.
BMC Cancer|July 1, 2026
Delaying surgery beyond six weeks after systemic therapy reduces postoperative morbidity without evidence of impaired oncologic outcomes in colorectal liver metastasesEsther Giehl-Brown, Rajan Nikbakhsh, Ana Mansourkiaei, et al.
Hepatology (Baltimore, Md.)|July 28, 2018
Schistosoma mansoni Egg-Secreted Antigens Activate Hepatocellular Carcinoma-Associated Transcription Factors c-Jun and STAT3 in Hamster and Human HepatocytesMartin Roderfeld, Sevinc Padem, Jakob Lichtenberger, et al.
Annals of Surgical Oncology|July 5, 2024
Prognostic Relevance of the Proximal Resection Margin Distance in Distal Gastrectomy for Gastric AdenocarcinomaIngmar F Rompen, Isabel Schütte, Nerma Crnovrsanin, et al.
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|October 18, 2008
Late enhancement in cardiac amyloidosis: correlation of MRI enhancement pattern with histopathological findingsWaldemar Hosch, Arnt V Kristen, Martin Libicher, et al.
Cancer Medicine|September 22, 2023
Association of perioperative use of statins, metformin, and aspirin with recurrence after curative liver resection in patients with hepatocellular carcinoma: A propensity score matching analysisElias Khajeh, Ehsan Aminizadeh, Arash Dooghaie Moghadam, et al.
World Journal of Gastroenterology|December 11, 2014
CYLD deletion triggers nuclear factor-κB-signaling and increases cell death resistance in murine hepatocytesToni Urbanik, Bruno Christian Koehler, Laura Wolpert, et al.
Pageof 23

Showing results (91-100 of 227) with videos related to

Sort By:
Pageof 23
International Journal of Oncology|November 19, 2014
Protumorigenic role of Timeless in hepatocellular carcinomaNahla Elgohary, Rossella Pellegrino, Olaf Neumann, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|January 19, 2010
Lipid droplet-associated PAT-proteins show frequent and differential expression in neoplastic steatogenesisBeate K Straub, Esther Herpel, Stephan Singer, et al.
Gastroenterology Research and Practice|August 9, 2020
Mouse Models of Nonalcoholic Steatohepatitis: Head-to-Head Comparison of Dietary Models and Impact on Inflammation and Animal WelfareAndreas Kroh, Vanina Ivanova, Hannah Drescher, et al.
Hepatology (Baltimore, Md.)|June 4, 2013
Posttranscriptional destabilization of the liver-specific long noncoding RNA HULC by the IGF2 mRNA-binding protein 1 (IGF2BP1)Monika Hämmerle, Tony Gutschner, Hannah Uckelmann, et al.
BMC Cancer|July 1, 2026
Delaying surgery beyond six weeks after systemic therapy reduces postoperative morbidity without evidence of impaired oncologic outcomes in colorectal liver metastasesEsther Giehl-Brown, Rajan Nikbakhsh, Ana Mansourkiaei, et al.
Hepatology (Baltimore, Md.)|July 28, 2018
Schistosoma mansoni Egg-Secreted Antigens Activate Hepatocellular Carcinoma-Associated Transcription Factors c-Jun and STAT3 in Hamster and Human HepatocytesMartin Roderfeld, Sevinc Padem, Jakob Lichtenberger, et al.
Annals of Surgical Oncology|July 5, 2024
Prognostic Relevance of the Proximal Resection Margin Distance in Distal Gastrectomy for Gastric AdenocarcinomaIngmar F Rompen, Isabel Schütte, Nerma Crnovrsanin, et al.
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|October 18, 2008
Late enhancement in cardiac amyloidosis: correlation of MRI enhancement pattern with histopathological findingsWaldemar Hosch, Arnt V Kristen, Martin Libicher, et al.
Cancer Medicine|September 22, 2023
Association of perioperative use of statins, metformin, and aspirin with recurrence after curative liver resection in patients with hepatocellular carcinoma: A propensity score matching analysisElias Khajeh, Ehsan Aminizadeh, Arash Dooghaie Moghadam, et al.
World Journal of Gastroenterology|December 11, 2014
CYLD deletion triggers nuclear factor-κB-signaling and increases cell death resistance in murine hepatocytesToni Urbanik, Bruno Christian Koehler, Laura Wolpert, et al.
Pageof 23